IPO of GPT Healthcare Limited to open on February 22, Check price band

Chennai: Eastern India-focused GPT Healthcare, which operates and manages mid-sized multispecialty hospitals under the ILS Hospitals brand, has fixed the price band of Rs 177- to Rs 186 per Equity Share of face value Rs 10/- each for its maiden initial public offer.  The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Thursday, February 22, 2024, for subscription and close on Monday, February 26, 2024. Investors can bid for a minimum of 80 Equity Shares and in multiples of 80 Equity Shares thereafter.

The issue consists of a fresh issue of equity shares worth Rs  40 crore and an offer for sale (OFS) of up to 26.08 million equity shares by investors selling shareholders.

Read Also : MNRE Announces Amendment to ALMM Order 2019 to Advance Solar Manufacturing

As per the DRHP, the proceeds from the fresh issue to the extent of Rs  30 crore will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the Company besides general corporate purposes.

GPT Healthcare, founded by Dwarika Prasad Tantia, Dr Om Tantia and Shree Gopal Tantia started with a 8 bed hospital at Salt Lake, Kolkata in 2000. Today it operates four full service multispecialty hospitals, with a total capacity of 561 beds and attends to over 35 specialties and super specialties such as internal medicine, diabetology, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurology, neurosurgery, paediatrics and neonatology.

Dr. Om Tantia, has over 4 decades of experience as a surgeon and is a specialist in the field of laparoscopic surgery. He has been the president of the Association of Minimal Access Surgeons of India along with multiple accolades to his credit, including the honorary professorship bestowed by the Indian Medical Association.

Read Also : CMD NBCC inaugurates program on application of AI and GEN AI in HR functions in PSU’s

Its total income increased 7.3% to Rs 3610.37 million in fiscal year 2023 from Rs  3374.15 million in fiscal year 2022, primarily due to the increases in income from hospital services, aided by increase in patient volume; increase in income from pharmacy sales. For the six months ended September 30, 2023, revenue from operations stood at Rs  2,041.76 million and net profit at Rs  234.85 million.

JM Financial is the sole book running lead manager and Link Intime India Private Limited is the registrar of the offer. The equity shares are proposed to be listed on the BSE and NSE.

Read Also : THDCIL Kicks Off National Level Water Sports Cup 2024 at Tehri